Product name: Vancomycin for Injection
Shelf Life: 3 Years
Vancomycin hydrochloride for Injection
This product is suitable for infection caused by Staphylococcus aureus and other bacteria: septicaemia, infective endocarditis, osteomyelitis, arthritis, burns, surgical trauma and other superficial excite infection, pneumonia, lung abscess, empyema, peritonitis, meningitis.
Usage and dosage
Usually with vancomycin hydrochloric acid 2g (titer) per day (titer), can be divided into 6 hours per hour 500mg or every 12 hours 1g, each time more than 60 minutes, according to age, weight, and the amount of symptoms to decrease. The old people are dripping for 60 minutes or more every 12 hours 500mg or 1g every 24 hours. The dosage of the newborn was given 10 - 15mg/kg each time, and the newborn was born every 12 hours a week. One week to one month, the newborn was given the medicine once every 8 hours, and each time was more than 60 minutes. The dispensing method was dissolved by 10mL injection in a small bottle containing 0.5g, diluted with at least 100mL normal saline or 5% Glucose Injection, and the time was more than 60 minutes.
Side effects caused by intravenous drip: rapid intravenous drip of vancomycin, or after, may occur as an allergic reaction, including hypotension, wheezing, dyspnea, urticaria or pruritus. Rapid intravenous drip may also cause flushing ("red neck") or pain and chest and back muscle twitch in the upper part of the body. These reactions are usually relieved within 20 minutes, but they may last for several hours. If vancomycin is dripped slowly for more than 60 minutes, this is rare. In healthy subjects, if 10mg / min or lower speed infusion, less adverse reactions will occur. Nephrotoxicity: in patients who use this product, there is little increase in serum creatinine or BUN concentration or interstitial nephritis. These cases usually occur in patients with the combination of aminoglycoside drugs, or the original patients with renal insufficiency, when vancomycin is discontinued, and most of the patients can restore normal azotoxemia. Ototoxicity: there are reports of the use of vancomycin with hearing loss, most of which are renal dysfunction, preexisting hearing loss, or at the same time with other ototoxic drugs. Dizziness, glare, and tinnitus are rarely reported. Hematopoiesis: reports of reversible neutropenia after 1 weeks or weeks of vancomycin, or more than 25g, are reported to have reversible neutropenia. When this product is discontinued, neutropenia can be quickly restored to normal. Reversible granulocytic deficiency (granulocytic < 500 / mm3) is rarely reported, and the reason is unclear. Thrombocytopenia is rare. Phlebitis: it has been reported at the injection site. Other: the use of vancomycin, even anaphylaxis, drug fever, chills, nausea, eosinophil, rash, Stevens Johnson syndrome, toxic epidermal necrosis, and rare vasculitis.
Those who are allergic to this product, severe liver and renal insufficiency, pregnant women and lactating women are prohibited.